Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure

Journal of the American College of Cardiology

Volumn 29, Issue 2, 1997, Pages 416-421

  Mulder, Paul ^a   Richard, Vincent ^a   Compagnon, Patricia ^a   Henry, Jean Paul ^a   Lallemand, Françoise ^a   Clozel, Jean Paul ^a   Koen, Robert ^a   Macé, Bertrand ^a   Thuillez, Christian ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIBEFRADIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HEART FAILURE; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CARDIAC OUTPUT, LOW; CATECHOLAMINES; HEMODYNAMIC PROCESSES; MALE; MIBEFRADIL; RATS; RATS, WISTAR; RENIN; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME;

EID: 0031019537     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00491-3     Document Type: Article

References (38)

1. Yusuf S. Calcium antagonists in coronary artery disease and hypertension: time for reevaluation? Circulation 1995;92:1079-82.
2. Braunwald E. Calcium channel blockers: pharmacological considerations. Am Heart J 1982;104:665-71.
3. Stone DL, Stevens JD, Banin SO. Coronary haemodynamic effects of nifedipine: comparison with glyceryl trinitrate. Br Heart J 1983;49:442-6.
4. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989;299: 1187-92.
5. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1989;319:385-92.
6. Figulla HR, Zeymer U, Raiber M, Hegselmann J, Soballar R, Hilgers R. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy: results of the diltiazem in dilated cardiomyopathy. Circulation 1996;94:346-52.
7. Leenen FHH, Holiwell DL. Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy. Am J Cardiol 1992;69:639-45.
8. Elkayama U, Amin J, Merha A, Vasquez J, Weber L, Rahimtoola SH. A prospective, randomized, double-blind, cross over study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-61.
9. 3H]desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts. Cardiovasc Drug Ther 1990;4:731-6.
10. Ezzaher A, Houda NL, Bouanani H, Su JB, Hittinger L, Crozatier B. Increased negative inotropic effects of calcium channel blockers in hypertrophied and failing rabbit heart. J Pharmacol Exp Ther 1991;257:466-71.
11. 2+ channels by Ro 40-5967. Circ Res 1994;75:144-8.
12. 2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 1989;13:754-9.
13. Véniant M, Clozel JP, Hess P, Wolfgang R. Ro 40-5967, in contrast with diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol 1991;17:277-84.
14. Vander Heide RS, Schwartz LM, Reimer KA. The novel calcium antagonist Ro 40-5967 limits infarct size in the dog. Cardiovasc Res 1994;28:1526-32.
15. Richard V, Tron C, Blanc T, Thuillez C. Infarct-size limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel blocker, in anesthetized rats: comparison with verapamil. J Cardiovasc Pharmacol 1995;25: 552-7.
16. Furukawa T, Ito H, Nitta J, et al. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocyte. Circ Res 1992;71:1242-53.
17. 2+ influx via T-type channels modulate PDGF-induced replication of mouse fibroblasts. Am J Physiol 1993;265: C1239-46.
18. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993;73:777-82.
19. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994;75:149-55.
20. Xu X, Best PM. Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Natl Acad Sci USA 1990;87:4655-9.
21. Mulder P, Elfertak L, Richard V, et al. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol 1996;271:H469-77.
22. Ménard LD, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radio immunoassay of angiotensin I. Endocrinology 1972;90:422-30.
23. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
24. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
25. Gaudron P, Blumrich M, Ertl G. Aggravation of left ventricular dilatation and reduction of survival by a calcium channel blocker in rats with chronic myocardial infarction. Am Heart J 1993;125:1226-33.
26. Wollert KC, Studer R, Just H, Drexler H. Influence of lisinopril on long-term mortality in rats with chronic myocardial infarction: role of blood pressure reduction and tissue ACE inhibition. Circulation 1994;90:2457-67.
27. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circ Res 1985;72:406-12.
28. Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Giudicelli JF. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol 1992;20:147-56.
29. Clozel JP, Osterrieder W, Kleinbloesem CH, et al. Ro 490-5967: a new nondihydropyridine calcium antagonist. Cardiovasc Drug Rev 1991;9:4-17.
30. Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1955:2815-25.
31. Tsoporis J, Leenen FHH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension 1988;11:376-86.
32. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Circ Res 1991;83:1849-65.
33. 2 receptor modulates T-type calcium current in nondifferentiated NG108-45 cells. FEBS Lett 1992;209:161-4.
34. McCarthy RT, Isales C, Rasmussen H. T-type calcium channels in adrenal glomerulosa cells: GTP-dependent modulation by angiotensin II. Proc Natl Acad Sci USA 1993;90:3260-4.
35. Rossier MF, Python CP, Capponi AM, Schlegel W, Kwan CY, Vallotton MB. Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells. Endocrinology 1993;132:1035-43.
36. Robert V, Van Thiem N, Cheavy SL, Mouas C, Swynghedauw B, Delcayre C. Increased cardiac types I and II collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994;24:30-6.
37. Drexler H, Flaim S, Fields R, Zelis R. Effects of nisoldipine on cardiocirculatory dynamics and cardiac output distribution in a conscious rats at rest and during treadmill exercise. J Pharmacol Exp Ther 1985;232:376-81.
38. Drexler H, Depenbusch J, Truog A, Zelis R, Flaim S. Effects of diltiazem on cardiac function and regional blood flow at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial infarction). Circulation 1985;71:1262-73.